Skip to content

Cardiac Preconditioning Effect of Remote Ischemia and Nicorandil in Patients Undergoing Elective Percutaneous Coronary Intervention.

Cardiac Preconditioning Effect of Remote Ischemia and Nicorandil in Patients Undergoing Elective Percutaneous Coronary Intervention. - RINC study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005607
Enrollment
399
Registered
2011-06-01
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stable myocardial ischemia who undergo elective PCI.

Interventions

Control: Subjects who do not undergo any pre-treatment before PCI. RIPC: Subjects who undergo RIPC pre-treatment induced by three 5-minute inflations of a blood pressure cuff to 200mmHg around the

Sponsors

Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Silent myocardial ischemia or stable angina pectoris patient. 2. Over 20 years old patient.

Exclusion criteria

Exclusion criteria: 1. Acute coronary syndrome patient undergoing emergency PCI. 2. Patient corresponded contra- indication of intravenous Nicorandil administration. 3. Patient undergoing PCI to chronic total occlusion lesion or patients undergoing PCI with rotablator. 4. Diabetes patient treated with glibenclamide. 5. Patient with AV shunt on the arms 6. Patient whose prognosis is regarded as less than 12 months. 7. Patient considered to be improper to this study by attending doctor.

Design outcomes

Primary

MeasureTime frame
The ratio of patients with acute myocardial infarction associated with PCI employing the 2007 universal definition by the joint ESC-AHA-ACC-WHF task force.

Secondary

MeasureTime frame
1. Ischemic event during PCI and 8 months MACE after PCI procedure 2. safety of RIPC and Nicorandil

Countries

Japan

Contacts

Public ContactKunihisa Kohno

Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Cardiovascular Medicine

kunihisakohno@msn.com086-235-7351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026